tiprankstipranks
Lumos Pharma (LUMO)
NASDAQ:LUMO
US Market

Lumos Pharma (LUMO) Financial Statements

332 Followers

Lumos Pharma Financial Overview

Lumos Pharma's market cap is currently ―. The company's EPS TTM is $-4.589; its P/E ratio is -0.32; Lumos Pharma is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 165.00K$ 7.00K$ 527.00K$ 691.00K$ 512.00K
Gross Profit$ 165.00K$ 7.00K$ 527.00K$ 691.00K$ 512.00K
EBIT$ -10.44M$ -8.93M$ -8.96M$ -7.35M$ -8.76M
EBITDA$ -10.44M$ -8.92M$ -8.95M$ -7.34M$ -8.73M
Net Income Common Stockholders$ -10.44M$ -8.30M$ -8.93M$ -7.35M$ -8.25M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 23.20M$ 42.69M$ 50.85M$ 57.98M$ 67.36M
Total Assets$ 28.08M$ 47.75M$ 56.37M$ 63.73M$ 72.29M
Total Debt$ 518.00K$ 269.00K$ 346.00K$ 421.00K$ 233.00K
Net Debt$ -22.68M$ -42.42M$ -50.51M$ -57.56M$ -67.13M
Total Liabilities$ 10.64M$ 12.26M$ 12.71M$ 11.21M$ 12.71M
Stockholders Equity$ 17.44M$ 35.49M$ 43.66M$ 52.52M$ 59.58M
Cash Flow-
Free Cash Flow$ -12.89M$ -7.82M$ -6.68M$ -9.20M$ -5.85M
Operating Cash Flow$ -12.89M$ -7.82M$ -6.68M$ -9.20M$ -5.83M
Investing Cash Flow$ 1.00M$ 5.95M$ 1.08M$ -2.46M$ -11.36M
Financing Cash Flow$ -5.00K$ -435.00K$ -574.00K$ -309.00K$ -475.00K
Currency in USD

Lumos Pharma Earnings and Revenue History

Lumos Pharma Debt to Assets

Lumos Pharma Cash Flow

Lumos Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis